Stocks · Healthcare · Medical - Care Facilities
Pediatrix Medical Group, Inc. MD
$25.97 +0.82% Close, Oct 2, 2026 · NYSE · Market cap $2.13B
Inexpensive vs sectorLow risk
Next earnings report: Nov 2, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $2.09, up 64.6% year over year.
- The stock is in an uptrend: above its 200-day average for 292 trading days, with the 50-day average above the 200-day.
- The diluted share count fell 6.3% in a year, mainly through buybacks.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 30%
- EPS growth (TTM, YoY)Top 22%
- FCF growth (TTM, YoY)Bottom 40%
- Revenue growth, 3-year CAGRBottom 21%
- Revenue growth accelerationTop 24%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 15%
- Gross marginBottom 17%
- Operating marginTop 23%
- Cash conversion (OCF / net income)Bottom 41%
- Accruals (lower is better)Bottom 31%
- Net debt / EBITDA (lower is better)Bottom 50%
- Interest coverTop 18%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 4%
- Free-cash-flow yieldTop 7%
- EBITDA / enterprise valueTop 7%
- Sales / enterprise valueTop 15%
- P/E vs own 5-year history (lower is better)Bottom 37%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 30%
- 6-month returnTop 37%
- 1-year return vs S&P 500Top 26%
- Distance from 52-week highTop 10%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 29%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 7%
- Upside to consensus price targetBottom 12%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 16%
- Maximum drawdown, 3 yearsTop 21%
- Beta vs S&P 500 (lower is better)Top 22%
- Net debt / EBITDA (lower is better)Bottom 50%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -2.3% | 0.5% | ↑ |
| Gross margin | 24.4% | 25.9% | ↑ |
| Operating margin | 8.5% | 11.6% | ↑ |
| FCF margin | 11.7% | 11.7% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 0.5% | -2.3% | ↑ | Bottom 30% |
| EPS growth (TTM, YoY) | 64.6% | — | Top 22% | |
| Gross margin | 25.9% | 24.4% | ↑ | Bottom 17% |
| Operating margin | 11.6% | 8.5% | ↑ | Top 23% |
| Net margin | 9.0% | 5.7% | ↑ | — |
| Free-cash-flow margin | 11.7% | 11.7% | ↑ | — |
| Return on invested capital | 9.6% | — | Top 15% | |
| Revenue growth, 3-year CAGR | -1.0% | — | Bottom 21% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.41×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -3.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.24×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 8.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 6.85%
- Shareholder yield
- 6.85%
- Share count change, 1 year
- -6.3%
- Share count change, 3-year CAGR
- -0.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +16.4%
- Average 2-day reaction, last 8
- +7.7%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $26.60
- Target vs current price
- +2.4%
- Analysts with a rating
- 33
- Share rating Buy or Strong Buy
- 39%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | +6.6% | -5.9% | -0.6% | -0.1% | — |
| May 5, 2026 | +18.9% | -7.1% | +4.3% | -2.9% | +18.2% |
| Feb 19, 2026 | -5.7% | -12.2% | -9.4% | -9.7% | +6.9% |
| Nov 3, 2025 | +45.7% | +24.2% | +29.2% | +41.9% | +23.7% |
| Aug 5, 2025 | +26.2% | +5.0% | +14.8% | +37.2% | +45.0% |
| May 6, 2025 | +32.0% | +11.8% | +10.9% | +6.6% | -5.4% |
| Feb 20, 2025 | +37.8% | +22.1% | +6.3% | +0.9% | +5.5% |
| Nov 1, 2024 | +18.9% | +23.5% | +30.2% | +21.4% | +17.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $0.63 | $0.59 | +6.6% | $487.8M |
| May 5, 2026 | $0.44 | $0.37 | +18.9% | $476.2M |
| Feb 19, 2026 | $0.50 | $0.53 | -5.7% | $493.8M |
| Nov 3, 2025 | $0.67 | $0.46 | +45.7% | $492.9M |
| Aug 5, 2025 | $0.53 | $0.42 | +26.2% | $468.8M |
| May 6, 2025 | $0.33 | $0.25 | +32.0% | $458.4M |
| Feb 20, 2025 | $0.51 | $0.37 | +37.8% | $502.4M |
| Nov 1, 2024 | $0.44 | $0.37 | +18.9% | $511.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 12.4× | 12.0× | 57th | Top 4% |
| P/E (forward) | 11.1× | — | — | — |
| EV / EBITDA | 9.2× | — | — | Top 7% |
| EV / Sales | 1.26× | — | — | Top 15% |
| Free-cash-flow yield | 10.74% | — | — | Top 7% |
| Earnings yield | 8.05% | — | — | Top 4% |
P/E over the past five years
Range 8.8× – 126.2× since Sep 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +52.8%
- Earnings per share growth (TTM)
- +64.6%
- Change in P/E multiple
- +16.2%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 292
- 50-day average slope (20 days)
- +0.6%
- 200-day average slope (20 days)
- +1.4%
- Distance from 50-day average
- -1.5%
- Distance from 200-day average
- +11.5%
- RSI (14)
- 47.4
- Relative volume
- 0.81×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 35.1%
- Volatility vs own 5-year history
- 20th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.62
- Correlation with S&P 500
- 0.21
- Current drawdown from 1-year high
- -5.2%
- Maximum drawdown, 3 years
- -47.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Aug 30, 2021 | Jun 11, 2024 | -80.7% | 699 days | Not yet recovered |
| Jan 27, 2021 | Feb 18, 2021 | -27.2% | 15 days | 55 days (May 7, 2021) |
| Oct 5, 2020 | Oct 28, 2020 | -26.2% | 17 days | 8 days (Nov 9, 2020) |
| Jun 9, 2021 | Jul 16, 2021 | -16.1% | 26 days | 18 days (Aug 11, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.13B
- P/E (TTM)
- 12.4
- EPS, diluted (TTM)
- $2.09
- Revenue (TTM)
- $1.95B
- 52-week range
- $15.70 – $27.94
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.91B | $1.97B | $1.99B | $2.01B | $1.91B |
| Gross profit | $513.2M | $467.0M | $421.6M | $454.3M | $471.9M |
| Operating income | $202.9M | $172.7M | $7.3M | -$68.7M | $231.1M |
| Net income | $131.0M | $66.3M | -$60.4M | -$99.1M | $165.4M |
| EPS (diluted) | $1.52 | $0.79 | -$0.73 | -$1.19 | $1.94 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $511.2M | $502.4M | $458.4M | $468.8M | $492.9M | $493.8M | $476.2M | $487.8M |
| Net income | $19.4M | $30.5M | $20.7M | $39.3M | $71.7M | $33.7M | $29.6M | $39.8M |
| EPS (diluted) | $0.23 | $0.35 | $0.24 | $0.45 | $0.84 | $0.40 | $0.36 | $0.49 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $76.7M | $166.9M | $137.3M | $206.6M | $271.1M |
| Capital expenditure | -$32.2M | -$29.7M | -$33.3M | -$22.0M | -$18.5M |
| Free cash flow | $44.5M | $137.2M | $104.0M | $184.6M | $252.6M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $2.1M | -$83.1M | $4.0M | $1.9M | -$83.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $404.2M
- Total assets
- $2.13B
- Total liabilities
- $1.25B
- Total debt
- $620.0M
- Net debt
- $331.1M
- Shareholders’ equity
- $881.0M
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 4,730,174
- Days to cover
- 6.90
- Change vs previous report
- -1.8%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Dec 20, 2013
- 2-for-1
- Apr 28, 2006
- 2-for-1
- Mar 1, 1999
- 2-for-1